Roxro Files Rapid-acting Nasal Pain Spray
This article was originally published in The Pink Sheet Daily
Executive Summary
Specialty pharma reinvents generic ketorolac as hospital-strength pain med for short-term use at home.
You may also be interested in...
Allergan Promo For Acular LS Broadens Indications, FDA Warning Letter Says
Journal ad for the ophthalmic misleadingly suggests the drug is indicated for phacoemulsification, according to FDA.
Bristol Discontinues Serzone, Stadol And 15 Other Brands; Safety In Numbers?
Bristol will cease distribution of the antidepressant Serzone (nefazodone) effective June 14
Rare Disease Roundtable: Dealing With Pricing Pressure
Part 2: High costs are built into the rare disease business model. Participants at a roundtable discussion led by Scrip at the J.P. Morgan Healthcare Conference talked about how much they are feeling the pressure on pricing.